Matches in SemOpenAlex for { <https://semopenalex.org/work/W3150654683> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W3150654683 endingPage "53" @default.
- W3150654683 startingPage "49" @default.
- W3150654683 abstract "While oral iron supplementation is commonly used throughout many clinical setting,treatment with intravenous(IV) iron has historically been reserved for specific settings,such as chronic kidney disease,gynecologic issues,and anemia associated with cancer and its treatments.However,the use of IV iron has begun to gain popularity in the treatment of iron deficiency anemia(IDA) associated with two conditions that are being seen more frequently than in years past:patients who are status post gastric bypass procedure and those with inflammatory bowel disease(IBD).The Roux-en-Y procedure involves connecting a gastric pouch to the jejunum,creating a blind loop consisting of distal stomach,duodenum,and proximal jejunum that connects to the Roux limb to form a common tract.IDA occurs in 6%-50% of patients who have undergone a gastric bypass,the etiology being multifactorial.The proximal gastric pouch,the primary site of gastric acid secretion,is bypassed,resulting in a decreased ability to metabolize molecular iron.Once metabolized,most iron is absorbed in the duodenum,which is entirely bypassed.After undergoing bypass procedures,most patients significantly limit their intake of red meat,another factor contributing to post-bypass IDA.Chronic anemia occurs in approximately 1/3 of patients who suffer from IBD,and almost half of all IBD patients are iron deficient.IBD leads to IDA through multiple mechanisms,including chronic intestinal blood loss,decreased absorption capabilities of the duodenum secondary to inflammation,and an inability of many IBD patients to tolerate the side effects of oral ferrous sulfate.In this study,we reviewed the charts of all patients who received IV iron at Sylvester Comprehensive Cancer Center/University of Miami Hospital Clinic from January 2007 to May 2012.The most common indications for IV iron were for issues related to cancer and its treatment(21.9%),IBD(20.1%),and gastric bypass(15.0%).Of the 262 patients who received IV iron,230 received iron sucrose and 36 received iron dextran.While d" @default.
- W3150654683 created "2021-04-13" @default.
- W3150654683 creator A5004402064 @default.
- W3150654683 creator A5034809149 @default.
- W3150654683 creator A5087248638 @default.
- W3150654683 creator A5089666581 @default.
- W3150654683 date "2013-01-01" @default.
- W3150654683 modified "2023-09-25" @default.
- W3150654683 title "Emerging causes of iron deficiency anemia refractory to oral iron supplementation" @default.
- W3150654683 hasPublicationYear "2013" @default.
- W3150654683 type Work @default.
- W3150654683 sameAs 3150654683 @default.
- W3150654683 citedByCount "0" @default.
- W3150654683 crossrefType "journal-article" @default.
- W3150654683 hasAuthorship W3150654683A5004402064 @default.
- W3150654683 hasAuthorship W3150654683A5034809149 @default.
- W3150654683 hasAuthorship W3150654683A5087248638 @default.
- W3150654683 hasAuthorship W3150654683A5089666581 @default.
- W3150654683 hasConcept C126322002 @default.
- W3150654683 hasConcept C141071460 @default.
- W3150654683 hasConcept C2776366702 @default.
- W3150654683 hasConcept C2776732101 @default.
- W3150654683 hasConcept C2776809568 @default.
- W3150654683 hasConcept C2777417653 @default.
- W3150654683 hasConcept C2778248108 @default.
- W3150654683 hasConcept C2778281985 @default.
- W3150654683 hasConcept C2779422922 @default.
- W3150654683 hasConcept C71924100 @default.
- W3150654683 hasConcept C90924648 @default.
- W3150654683 hasConceptScore W3150654683C126322002 @default.
- W3150654683 hasConceptScore W3150654683C141071460 @default.
- W3150654683 hasConceptScore W3150654683C2776366702 @default.
- W3150654683 hasConceptScore W3150654683C2776732101 @default.
- W3150654683 hasConceptScore W3150654683C2776809568 @default.
- W3150654683 hasConceptScore W3150654683C2777417653 @default.
- W3150654683 hasConceptScore W3150654683C2778248108 @default.
- W3150654683 hasConceptScore W3150654683C2778281985 @default.
- W3150654683 hasConceptScore W3150654683C2779422922 @default.
- W3150654683 hasConceptScore W3150654683C71924100 @default.
- W3150654683 hasConceptScore W3150654683C90924648 @default.
- W3150654683 hasIssue "3" @default.
- W3150654683 hasLocation W31506546831 @default.
- W3150654683 hasOpenAccess W3150654683 @default.
- W3150654683 hasPrimaryLocation W31506546831 @default.
- W3150654683 hasRelatedWork W1203091343 @default.
- W3150654683 hasRelatedWork W181017102 @default.
- W3150654683 hasRelatedWork W1976394811 @default.
- W3150654683 hasRelatedWork W199013693 @default.
- W3150654683 hasRelatedWork W2013306215 @default.
- W3150654683 hasRelatedWork W2023434389 @default.
- W3150654683 hasRelatedWork W2041708177 @default.
- W3150654683 hasRelatedWork W2298928644 @default.
- W3150654683 hasRelatedWork W2517960584 @default.
- W3150654683 hasRelatedWork W2541843390 @default.
- W3150654683 hasRelatedWork W2563909556 @default.
- W3150654683 hasRelatedWork W2580061878 @default.
- W3150654683 hasRelatedWork W2735427613 @default.
- W3150654683 hasRelatedWork W2795472635 @default.
- W3150654683 hasRelatedWork W2939199322 @default.
- W3150654683 hasRelatedWork W2981198323 @default.
- W3150654683 hasRelatedWork W3040796556 @default.
- W3150654683 hasRelatedWork W3115784891 @default.
- W3150654683 hasRelatedWork W3149250978 @default.
- W3150654683 hasRelatedWork W3183907644 @default.
- W3150654683 isParatext "false" @default.
- W3150654683 isRetracted "false" @default.
- W3150654683 magId "3150654683" @default.
- W3150654683 workType "article" @default.